Literature DB >> 15882516

[Pathogenesis of primary nonalcoholic fatty liver disease].

Diego Moreno Sánchez1.   

Abstract

The challenges of growing prevalence and evident trend to progressive damage of primary nonalcoholic fatty liver disease confront a poorly understood pathogenesis. It appears to develop in two steps. First, a high adipocyte protein production in the context of a silent inflammatory background causes insulin resistance in adipose tissue. It leads both to lipolysis, with increase of the circulating and hepatic uptake of free fatty acids, and hyperinsulinemia. Within hepatocytes, the subsequent lipogenesis, together with a decreased secretion of lipoproteins, induces an accumulation of excessive hepatic triglycerides (steatosis), impliying some oxidative damage, but it remain balanced by uncoupling protein upregulation and antioxidant systems activation. Second, a more forceful fat catabolism by beta and omega oxidation results in respiratory chain hyperactivity with overproduction of free radicals and reactive oxygen species that exceed the antioxidant capacity. These agents lead to hepatocellular injury and necrosis, inflammatory infiltration and fibrosis (steatohepatitis) through induction of Fas ligand and cytokines (tumor necrosis factor alpha, transforming growth factor beta, interleukin-8), and lipid peroxidation and by-products (malondialdehyde and 4-hydroxynonenal). Other mechanisms (hepatic iron, Kupffer cells dysfunction or endotoxemia) play uncertain roles.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15882516     DOI: 10.1157/13074744

Source DB:  PubMed          Journal:  Med Clin (Barc)        ISSN: 0025-7753            Impact factor:   1.725


  4 in total

1.  Study of Cellular Senescence and Vitamin D Deficiency in Nonalcoholic Fatty Liver Disease and The Potential Protective Effect of Vitamin D Supplementation.

Authors:  Hasen A Al-Ghamdi; Fayza F Al Fayez; Abdulhadi I Bima; Taghreed M Khawaji; Ayman Z Elsamanoudy
Journal:  J Clin Exp Hepatol       Date:  2020-07-18

Review 2.  Metabolic Imaging in Non-Alcoholic Fatty Liver Disease: Applications of Magnetic Resonance Spectroscopy.

Authors:  Prarthana Thiagarajan; Stephen J Bawden; Guruprasad P Aithal
Journal:  J Clin Med       Date:  2021-02-07       Impact factor: 4.241

3.  Prevalence and factors associated with the presence of non alcoholic fatty liver disease in an apparently healthy adult population in primary care units.

Authors:  Llorenç Caballería; Ma Antonia Auladell; Pere Torán; Dolores Miranda; Jesús Aznar; Guillem Pera; Dolors Gil; Laura Muñoz; Jaume Planas; Santiago Canut; Jesús Bernad; Josep Aubà; Gregorio Pizarro; Miren Maite Aizpurua; Anna Altaba; Albert Tibau
Journal:  BMC Gastroenterol       Date:  2007-11-05       Impact factor: 3.067

4.  Correlation of blood glucose, serum chemerin and insulin resistance with NAFLD in patients with type 2 diabetes mellitus.

Authors:  Zhengjun Zhang; Jijun Wang; Hongmei Wang
Journal:  Exp Ther Med       Date:  2018-01-16       Impact factor: 2.447

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.